Mark Salvati
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Endocrinology, Diabetes and Metabolism top 5%
- Genetics top 5%
- Organic Chemistry top 10%
- Co-authors
- Ricardo M. AttarRoberto WeinmannStanley R. KrystekJohn S. SackYongmi AnMichael NguyenKevin KishRobert W. Armstrong
- Topics
- Cancer Immunotherapy and Biomarkers (14 papers)CAR-T cell therapy research (12 papers)Prostate Cancer Treatment and Research (11 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of the American Chemical SocietyJournal of Clinical Oncology
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Mark Salvati
45 papers receiving 996 citations
Peers
Comparison fields: 5 of 74
- Pulmonary and Respiratory Medicine 403
- Molecular Biology 399
- Endocrinology, Diabetes and Metabolism 359
- Genetics 357
- Organic Chemistry 191
Countries citing papers authored by Mark Salvati
This map shows the geographic impact of Mark Salvati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Salvati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Salvati more than expected).
Fields of papers citing papers by Mark Salvati
This network shows the impact of papers produced by Mark Salvati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Salvati. The network helps show where Mark Salvati may publish in the future.
Co-authorship network of co-authors of Mark Salvati
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Salvati. A scholar is included among the top collaborators of Mark Salvati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Salvati. Mark Salvati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 2 | |
| 7 | 8 | |
| 8 | 1 | |
| 9 | 5 | |
| 10 | 5 | |
| 11 | 92 | |
| 12 | 38 | |
| 13 | 20 | |
| 14 | 19 | |
| 15 | 20 | |
| 16 | 22 | |
| 17 | 25 | |
| 18 | 33 | |
| 19 | 48 | |
| 20 | 3 |
About Mark Salvati
Mark Salvati is a scholar working on Oncology, Pharmaceutical Science and Endocrinology, Diabetes and Metabolism, having authored 48 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), CAR-T cell therapy research (12 papers) and Prostate Cancer Treatment and Research (11 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (359 citations), Genetics (357 citations) and Pulmonary and Respiratory Medicine (403 citations). Mark Salvati has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Ricardo M. Attar, Roberto Weinmann, Stanley R. Krystek, John S. Sack, Yongmi An, Michael Nguyen, Kevin Kish, Robert W. Armstrong, Chihuei Wang and Susan E. Kiefer. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.